First in Human of Single and Multiple Doses of MOR106
Clinical trial NCT02739009 · COMPLETED
Trial details
- NCT number
- NCT02739009
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-08-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.